Sivaranjani Namasivayam

11PUBLICATIONS
78CO-AUTHORS
Medical mycologyInnate immunityHaematological tumoursMedical parasitologyMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 25, 2026
IFNγ blockade in Mycobacterium tuberculosis infected macaques alters the granuloma environment but not bacterial control.

|Dec 12, 2023
Bacterial-induced or passively administered interferon gamma conditions the lung for early control of SARS-CoV-2.

Kerry L Hilligan, Sivaranjani Namasivayam, Chad S Clancy

|Dec 08, 2023
BACH1 promotes tissue necrosis and Mycobacterium tuberculosis susceptibility.

Eduardo P Amaral, Sivaranjani Namasivayam, Artur T L Queiroz

|Aug 11, 2023
Exposure to lung-migrating helminth protects against murine SARS-CoV-2 infection through macrophage-dependent T cell activation.

Oyebola O Oyesola, Kerry L Hilligan, Sivaranjani Namasivayam

|Sep 07, 2022
GPX4 regulates cellular necrosis and host resistance in Mycobacterium tuberculosis infection.

Eduardo P Amaral, Taylor W Foreman, Sivaranjani Namasivayam

|Mar 10, 2022
Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues.

Christine E Nelson, Sivaranjani Namasivayam, Taylor W Foreman

Pageof 2

Frequent Collaborators

9 joint publications

Alan Sher

6 joint publications

Katrin D Mayer-Barber

5 joint publications

Kerry L Hilligan

4 joint publications

Bernard A P Lafont